T1	Pharmacological_substance 10 25	Succinylcholine
N1000 	Reference T1 MeSH:D013390	Succinylcholine
T2	Disorder 34 46	hyperkalemia
N1 	Reference T2 UMLS:C0020461	hyperkalemia
T3	Disorder 65 74	mucositis
N2 	Reference T3 UMLS:C0333355	mucositis
T4	Disorder 140 152	hyperkalemia
N3 	Reference T4 UMLS:C0020461	hyperkalemia
T5	Pharmacological_substance 162 177	succinylcholine
N1001 	Reference T5 MeSH:D013390	succinylcholine
T6	Disorder 211 220	mucositis
N4 	Reference T6 UMLS:C0333355	mucositis
T7	Disorder 376 385	mucositis
N5 	Reference T7 UMLS:C0333355	mucositis
T8	Disorder 487 513	acute myelogenous leukemia
N6 	Reference T8 UMLS:C0023467	acute myelogenous leukemia
T9	Disorder 569 588	progressive dyspnea
N7 	Reference T9 UMLS:C0013404	progressive dyspnea
T10	Disorder 698 707	mucositis
N8 	Reference T10 UMLS:C0333355	mucositis
T11	Disorder 723 732	dysphagia
N9 	Reference T11 UMLS:C0011168	dysphagia
T12	Disorder 737 745	bleeding
N10 	Reference T12 UMLS:C0019080	bleeding
T14	Disorder 981 1001	respiratory distress
N11 	Reference T14 UMLS:C0476273	respiratory distress
T16	Pharmacological_substance 1085 1094	etomidate
N1002 	Reference T16 MeSH:D005045	etomidate
T18	Pharmacological_substance 1109 1124	succinylcholine
N1003 	Reference T18 MeSH:D013390	succinylcholine
T19	Disorder 1187 1201	cardiac arrest
N12 	Reference T19 UMLS:C0018790	cardiac arrest
T20	Disorder 1361 1375	Oral mucositis
N13 	Reference T20 UMLS:C0038362	Oral mucositis
T21	Disorder 1466 1475	mucositis
N14 	Reference T21 UMLS:C0333355	mucositis
T22	Disorder 1524 1536	hyperkalemia
N15 	Reference T22 UMLS:C0020461	hyperkalemia
T23	Pharmacological_substance 1561 1576	succinylcholine
N1004 	Reference T23 MeSH:D013390	succinylcholine
T24	Disorder 1625 1639	thermal injury
N16 	Reference T24 UMLS:C0332685	thermal injury
T25	Pharmacological_substance 1646 1678	nondepolarizing muscle relaxants
T26	Disorder 1726 1735	mucositis
N17 	Reference T26 UMLS:C0333355	mucositis
T27	Disorder 1737 1746	Mucositis
N18 	Reference T27 UMLS:C0333355	Mucositis
T28	Pharmacological_substance 1798 1813	succinylcholine
N1005 	Reference T28 MeSH:D013390	succinylcholine
T29	Subject 50 59	a patient
T30	Subject 196 205	a patient
T33	Subject 359 370	One patient
T13	Subject 444 462	A 37-yr-old female
T34	Speculation_cue 757 764	thought
T40	Pharmacological_substance 1436 1448	chemotherapy
N1006 	Reference T40 MeSH:C403362	chemotherapy
N1007 	Reference T40 MeSH:D004113	chemotherapy
N1008 	Reference T40 MeSH:C057647	chemotherapy
T41	Disorder 1429 1435	cancer
N19 	Reference T41 UMLS:C0006826	cancer
N20 	Reference T41 UMLS:C1306459	cancer
T45	Pharmacological_substance 234 246	chemotherapy
N1009 	Reference T45 MeSH:C403362	chemotherapy
N1010 	Reference T45 MeSH:D004113	chemotherapy
N1011 	Reference T45 MeSH:C057647	chemotherapy
T47	Pharmacological_substance 88 100	chemotherapy
N1012 	Reference T47 MeSH:C403362	chemotherapy
N1013 	Reference T47 MeSH:D004113	chemotherapy
N1014 	Reference T47 MeSH:C057647	chemotherapy
T48	Disorder 543 564	mental status changes
N21 	Reference T48 UMLS:C0278061	mental status changes
T49	Pharmacological_substance 785 797	chemotherapy
N1015 	Reference T49 MeSH:C403362	chemotherapy
N1016 	Reference T49 MeSH:D004113	chemotherapy
N1017 	Reference T49 MeSH:C057647	chemotherapy
T50	Coreferring_mention 664 671	patient
T53	Speculation_cue 1679 1685	should
T36	Subject 1697 1705	patients
T42	Pharmacological_substance 399 411	chemotherapy
N1018 	Reference T42 MeSH:C403362	chemotherapy
N1019 	Reference T42 MeSH:D004113	chemotherapy
N1020 	Reference T42 MeSH:C057647	chemotherapy
T51	Coreferring_mention 1054 1065	The patient
